3 Hrs_1777293978995_62445876.jpg&w=64&q=75)
Source:
أخبار الخليج
Source: أخبار الخليج
3 Hrsأخبار الخليج
Source: أخبار الخليج
3 HrsReady to play
Ready to play
The Royal Medical Services at the Bahrain Oncology Center have successfully treated their third case of sickle cell disease using the gene-editing technology Casgevy. The treatment modifies blood-forming stem cells to stimulate the production of fetal hemoglobin and reduce painful crises, without requiring a stem cell donor.
Notice: This Is an AI-Generated Summary
Comments (0)